Market revenue in 2020 | USD 2,485.7 million |
Market revenue in 2027 | USD 5,190.2 million |
Growth rate | 11.1% (CAGR from 2020 to 2027) |
Largest segment | Spinal cord stimulator |
Fastest growing segment | Sacral Nerve Stimulator |
Historical data covered | 2016 - 2019 |
Base year for estimation | 2020 |
Forecast period covered | 2021 - 2027 |
Quantitative units | Revenue in USD million |
Market segmentation | Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Electric Stimulator |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nevro Corp, LivaNova PLC, NeuroPace Inc, Aleva Neurotherapeutics, Synapse Biomedical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable neurostimulators market will help companies and investors design strategic landscapes.
Spinal cord stimulator was the largest segment with a revenue share of 53.09% in 2020. Horizon Databook has segmented the North America implantable neurostimulators market based on spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, gastric electric stimulator covering the revenue growth of each sub-segment from 2016 to 2027.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America implantable neurostimulators market, including forecasts for subscribers. This continent databook contains high-level insights into North America implantable neurostimulators market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account